# Characteristics of Pts Initiating Spiriva Respimat in Asthma

> **NCT03692676** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 116133 (actual)

## Conditions studied

- Asthma

## Interventions

- **DEVICE:** Spiriva Respimat

## Key facts

- **NCT ID:** NCT03692676
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-05
- **Primary completion:** 2019-10-11
- **Final completion:** 2019-10-11
- **Target enrollment:** 116133 (ACTUAL)
- **Last updated:** 2025-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03692676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03692676, "Characteristics of Pts Initiating Spiriva Respimat in Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03692676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*